Canada's approach to SARS-CoV-2 sero-surveillance: Lessons learned for routine surveillance and future pandemics.
Sheila F O'BrienMichael Asamoah-BoahengBrian E GrunauMel KrajdenDavid L BuckeridgeDavid M GoldfarbMaureen AndersonMarc GermainPatrick E BrownDerek R SteinKami KandolaGraham TipplesPhillip AwadallaAmanda LangLesley BehlTiffany FitzpatrickSteven J DrewsPublished in: Canadian journal of public health = Revue canadienne de sante publique (2024)
To provide timely, high-quality information for public health decision-making, routine sero-surveillance systems must be adaptable, flexible, and scalable. National capability planning should include consortiums for assay design and validation, defined mechanisms to improve test capacity, base documents for data linkage and material transfer across jurisdictions, and mechanisms for real-time communication of data. Lessons learned will inform incorporation of a robust sero-survey program into routine surveillance with strategic sampling and capacity to adapt and scale rapidly as a part of a comprehensive national pandemic response plan.
Keyphrases
- public health
- sars cov
- quality improvement
- clinical practice
- decision making
- electronic health record
- coronavirus disease
- big data
- global health
- respiratory syndrome coronavirus
- genome wide
- cross sectional
- current status
- dna methylation
- machine learning
- hiv infected
- artificial intelligence
- social media
- gene expression
- hepatitis c virus